Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results from a Large Multicenter Trial.

Thompson JF, Haydu LE, Uren RF, Andtbacka RH, Zager JS, Beitsch PD, Agnese DM, Mozzillo N, Testori A, Bowles TL, Hoekstra HJ, Kelley MC, Sussman J, Schneebaum S, Smithers BM, McKinnon G, Hsueh E, Jacobs L, Schultz E, Reintgen D, Kane JM, Friedman EB, Wang H, Van Kreuningen L, Schiller V, Elashoff DA, Elashoff R, Cochran AJ, Stern S, Faries MB; MSLT-II Trial Group.

Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003405. [Epub ahead of print]

PMID:
31188198
2.

Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.

Nelson DW, Fischer TD, Graff-Baker AN, Dehal A, Stern S, Bilchik AJ, Faries MB.

Ann Surg Oncol. 2019 Jun 10. doi: 10.1245/s10434-019-07487-5. [Epub ahead of print]

PMID:
31183639
3.

Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.

Thomas DC, Han G, Leong SP, Kashani-Sabet M, Vetto J, Pockaj B, White RL, Faries MB, Schneebaum S, Mozzillo N, Charney KJ, Sondak VK, Messina JL, Zager JS, Han D.

Ann Surg Oncol. 2019 Jul;26(7):2254-2262. doi: 10.1245/s10434-019-07369-w. Epub 2019 Apr 22.

PMID:
31011906
4.

Re: "Time to Reconsider the Role of Sentinel Lymph Node Biopsy in Melanoma".

Faries MB, Cochran AJ, Thompson JF.

J Am Acad Dermatol. 2019 Mar 27. pii: S0190-9622(19)30508-0. doi: 10.1016/j.jaad.2019.03.064. [Epub ahead of print] No abstract available.

PMID:
30928469
5.

Microsatellitosis in Patients with Melanoma.

Karakousis GC, Gimotty PA, Leong SP, Pockaj BA, White RL, O'Donoghue C, Sinnamon AJ, Bartlett EK, Dueck AC, Gould Rothberg BE, Messina JL, Vetto JT, Sondak VK, Schneebaum S, Kashani-Sabet M, Han D, Faries MB, Zager JS; with the Sentinel Lymph Node Working Group.

Ann Surg Oncol. 2019 Jan;26(1):33-41. doi: 10.1245/s10434-018-7006-4. Epub 2018 Nov 12.

PMID:
30421045
6.

Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis.

Ecker BL, Kaur A, Douglass SM, Webster MR, Almeida FV, Marino GE, Sinnamon AJ, Neuwirth MG, Alicea GM, Ndoye A, Fane M, Xu X, Sim MS, Deutsch GB, Faries MB, Karakousis GC, Weeraratna AT.

Cancer Discov. 2019 Jan;9(1):82-95. doi: 10.1158/2159-8290.CD-18-0168. Epub 2018 Oct 2.

PMID:
30279172
7.

Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed.

Rand JG, Faries MB.

Ann Surg Oncol. 2018 Nov;25(12):3416-3418. doi: 10.1245/s10434-018-6744-7. Epub 2018 Sep 12. No abstract available.

PMID:
30209726
8.

Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials.

Faries MB, Han D, Reintgen M, Kerivan L, Reintgen D, Caracò C.

Clin Exp Metastasis. 2018 Aug;35(5-6):431-442. doi: 10.1007/s10585-018-9898-6. Epub 2018 May 18. Review.

PMID:
29777421
9.

More on Adjuvant Therapy in Resected Melanoma.

Faries MB, Stern S, Thompson JF.

N Engl J Med. 2018 Apr 26;378(17):1656-1657. doi: 10.1056/NEJMc1803342. No abstract available.

PMID:
29694823
10.

Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy.

Deutsch GB, Tyrell R, Yost S, Deutsch MB, Barkhoudarian G, Kelly DF, Faries MB.

J Am Acad Dermatol. 2018 Feb;78(2):419-421. doi: 10.1016/j.jaad.2017.07.059. No abstract available.

11.

Completing the Dissection in Melanoma: Increasing Decision Precision.

Faries MB.

Ann Surg Oncol. 2018 Mar;25(3):585-587. doi: 10.1245/s10434-017-6330-4. Epub 2018 Jan 4. No abstract available.

12.

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH.

Ann Surg Oncol. 2018 Feb;25(2):356-377. doi: 10.1245/s10434-017-6267-7. Epub 2017 Dec 13.

PMID:
29236202
13.

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH.

J Clin Oncol. 2018 Feb 1;36(4):399-413. doi: 10.1200/JCO.2017.75.7724. Epub 2017 Dec 12.

PMID:
29232171
14.

Regarding complications following completion lymphadenectomy.

Faries MB, Cochran AJ, Thompson JF.

Eur J Surg Oncol. 2017 Dec;43(12):2374-2375. doi: 10.1016/j.ejso.2017.09.024. Epub 2017 Nov 2. No abstract available.

PMID:
29103908
15.

Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform.

CA Cancer J Clin. 2017 Nov;67(6):472-492. doi: 10.3322/caac.21409. Epub 2017 Oct 13.

16.

Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.

Faries MB, Mozzillo N, Kashani-Sabet M, Thompson JF, Kelley MC, DeConti RC, Lee JE, Huth JF, Wagner J, Dalgleish A, Pertschuk D, Nardo C, Stern S, Elashoff R, Gammon G, Morton DL; MMAIT-IV Clinical Trial Group.

Ann Surg Oncol. 2017 Dec;24(13):3991-4000. doi: 10.1245/s10434-017-6072-3. Epub 2017 Oct 10.

PMID:
29019177
17.

Prognostic Value of Multiple Draining Lymph Node Basins in Melanoma: A Matched-Pair Analysis Based on the John Wayne Cancer Institute Experience.

Howard JH, Ozao-Choy JJ, Hiles JM, Sim MS, Faries MB.

Front Oncol. 2017 Aug 14;7:172. doi: 10.3389/fonc.2017.00172. eCollection 2017.

18.

Melanoma Sentinel-Node Metastasis.

Faries MB, Cochran AJ, Thompson JF.

N Engl J Med. 2017 Aug 31;377(9):892. doi: 10.1056/NEJMc1708918. No abstract available.

PMID:
28854100
19.

Mycobacterium bovis Bacillus Calmette-Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function.

Lardone RD, Chan AA, Lee AF, Foshag LJ, Faries MB, Sieling PA, Lee DJ.

Front Immunol. 2017 Aug 11;8:965. doi: 10.3389/fimmu.2017.00965. eCollection 2017.

20.

Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma.

Nelson DW, Stern S, Elashoff DE, Elashoff R, Thompson JF, Mozzillo N, Nieweg OE, Hoekstra HJ, Cochran AJ, Faries MB.

J Am Coll Surg. 2017 Aug;225(2):302-311. doi: 10.1016/j.jamcollsurg.2017.05.013. Epub 2017 Jun 28.

21.

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM.

N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.

22.

The prognostic importance of scalp location in primary head and neck melanoma.

Ozao-Choy J, Nelson DW, Hiles J, Stern S, Yoon JL, Sim MS, Faries MB.

J Surg Oncol. 2017 Sep;116(3):337-343. doi: 10.1002/jso.24679. Epub 2017 May 22.

23.

Is Pregnancy-Associated Melanoma Associated with Adverse Outcomes?

Jones MS, Lee J, Stern SL, Faries MB.

J Am Coll Surg. 2017 Jul;225(1):149-158. doi: 10.1016/j.jamcollsurg.2017.02.011. Epub 2017 Apr 27.

24.

Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guérin.

Yang J, Jones MS, Ramos RI, Chan AA, Lee AF, Foshag LJ, Sieling PA, Faries MB, Lee DJ.

Front Oncol. 2017 Apr 5;7:61. doi: 10.3389/fonc.2017.00061. eCollection 2017.

25.

Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy.

Deutsch GB, Flaherty DC, Kirchoff DD, Bailey M, Vitug S, Foshag LJ, Faries MB, Bilchik AJ.

JAMA Surg. 2017 Jul 1;152(7):672-678. doi: 10.1001/jamasurg.2017.0459.

26.

The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.

Jones MS, Jones PC, Stern SL, Elashoff D, Hoon DSB, Thompson J, Mozzillo N, Nieweg OE, Noyes D, Hoekstra HJ, Zager JS, Roses DF, Testori A, Coventry BJ, Smithers MB, Andtbacka R, Agnese D, Schultz E, Hsueh EC, Kelley M, Schneebaum S, Jacobs L, Bowles T, Kashani-Sabet M, Johnson D, Faries MB.

Ann Surg Oncol. 2017 Aug;24(8):2089-2094. doi: 10.1245/s10434-017-5775-9. Epub 2017 Feb 21.

27.

Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.

Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Grotz TE, Allred JB, Suman VJ, Brady MS, Tyler D, Wayne JD, Nelson H.

Ann Surg. 2017 Jan;265(1):192-196. doi: 10.1097/SLA.0000000000001670.

28.

Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure.

Zendejas B, Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Tyler D, Brady MS, Farley DR.

Surg Endosc. 2017 Aug;31(8):3313-3319. doi: 10.1007/s00464-016-5364-1. Epub 2016 Dec 7.

29.

Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.

Karakousis G, Gimotty PA, Bartlett EK, Sim MS, Neuwirth MG, Fraker D, Czerniecki BJ, Faries MB.

Ann Surg Oncol. 2017 Apr;24(4):952-959. doi: 10.1245/s10434-016-5646-9. Epub 2016 Nov 2.

30.

Second Primary Melanoma: Risk Factors, Histopathologic Features, Survival, and Implications for Follow-Up.

Jones MS, Torisu-Itakura H, Flaherty DC, Schoellhammer HF, Lee J, Sim MS, Faries MB.

Am Surg. 2016 Oct;82(10):1009-1013.

31.

Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology.

Faries MB.

Crit Rev Oncog. 2016;21(1-2):65-73. doi: 10.1615/CritRevOncog.2016017124. Review.

32.

Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.

Lee DY, Lau BJ, Huynh KT, Flaherty DC, Lee JH, Stern SL, O'Day SJ, Foshag LJ, Faries MB.

J Am Coll Surg. 2016 Jul;223(1):9-18. doi: 10.1016/j.jamcollsurg.2016.01.045. Epub 2016 Jan 29.

33.

Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five Decades.

Kirchoff DD, Deutsch GB, Foshag LJ, Lee JH, Sim MS, Faries MB.

Am Surg. 2016 Jan;82(1):1-5.

34.

Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial.

Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS.

J Am Coll Surg. 2016 Mar;222(3):253-60. doi: 10.1016/j.jamcollsurg.2015.11.010. Epub 2015 Nov 25.

35.

Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.

Lee DY, Huynh KT, Teng A, Lau BJ, Vitug S, Lee JH, Stern SL, Foshag LJ, Faries MB.

Ann Surg Oncol. 2016 Mar;23(3):1012-8. doi: 10.1245/s10434-015-4912-6. Epub 2015 Nov 19.

36.

Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.

Flaherty DC, Hoffner BW, Lau BJ, Hamid O, Faries MB.

J Surg Oncol. 2015 Dec;112(8):844-5. doi: 10.1002/jso.24078. Epub 2015 Oct 26.

37.

Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical Treatments.

Flaherty DC, Deutsch GB, Kirchoff DD, Lee J, Huynh KT, Lee DY, Foshag LJ, Bilchik AJ, Faries MB.

Am Surg. 2015 Oct;81(10):1005-9.

38.

Attitudes and Perceptions of Surgical Oncology Fellows on ACGME Accreditation and the Complex General Surgical Oncology Certification.

Lee DY, Flaherty DC, Lau BJ, Deutsch GB, Kirchoff DD, Huynh KT, Lee JH, Faries MB, Bilchik AJ.

Ann Surg Oncol. 2015 Nov;22(12):3776-84. doi: 10.1245/s10434-015-4688-8. Epub 2015 Jun 30.

PMID:
26122371
40.

Metastasectomy for stage IV melanoma.

Deutsch GB, Kirchoff DD, Faries MB.

Surg Oncol Clin N Am. 2015 Apr;24(2):279-98. doi: 10.1016/j.soc.2014.12.006. Epub 2015 Jan 27. Review.

PMID:
25769712
41.

From the guest editor: The sentinel node: evolution of the revolution. Introduction.

Faries MB.

Cancer J. 2015 Jan-Feb;21(1):1-2. doi: 10.1097/PPO.0000000000000095. No abstract available.

42.

MSLT-I-response of clinical trial investigators.

Faries MB, Cochran AJ, Thompson JF.

Nat Rev Clin Oncol. 2014 Nov;11(11). doi: 10.1038/nrclinonc.2014.65-c1. Epub 2014 Oct 14. No abstract available.

PMID:
25311349
43.

Melanoma vaccines: mixed past, promising future.

Ozao-Choy J, Lee DJ, Faries MB.

Surg Clin North Am. 2014 Oct;94(5):1017-30, viii. doi: 10.1016/j.suc.2014.07.005. Epub 2014 Aug 7. Review.

44.

Sentinel lymph node biopsy for melanoma: a plea to let the data be heard.

Thompson JF, Faries MB, Cochran AJ.

Ann Surg Oncol. 2014 Oct;21(11):3362-4. doi: 10.1245/s10434-014-3967-0. Epub 2014 Aug 8. No abstract available.

45.

A 20-year experience of hepatic resection for melanoma: is there an expanding role?

Faries MB, Leung A, Morton DL, Hari D, Lee JH, Sim MS, Bilchik AJ.

J Am Coll Surg. 2014 Jul;219(1):62-8. doi: 10.1016/j.jamcollsurg.2014.04.008. Epub 2014 May 10.

46.

Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels.

Leung AM, Lee AF, Ozao-Choy J, Ramos RI, Hamid O, O'Day SJ, Shin-Sim M, Morton DL, Faries MB, Sieling PA, Lee DJ.

Front Oncol. 2014 May 16;4:110. doi: 10.3389/fonc.2014.00110. eCollection 2014. Review.

47.

Sentinel-node biopsy in melanoma.

Thompson JF, Cochran AJ, Faries MB.

N Engl J Med. 2014 May 29;370(22):2149-50. doi: 10.1056/NEJMc1402989. No abstract available.

48.

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ, Kashani-Sabet M, Smithers BM, Paul E, Kraybill WG, McKinnon JG, Wang HJ, Elashoff R, Faries MB; MSLT Group.

N Engl J Med. 2014 Feb 13;370(7):599-609. doi: 10.1056/NEJMoa1310460.

49.

Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.

Leung AM, Morton DL, Ozao-Choy J, Hari DM, Shin-Sim M, Difronzo AL, Faries MB.

JAMA Surg. 2013 Sep;148(9):879-84. doi: 10.1001/jamasurg.2013.3044.

50.

Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification.

Falch C, Stojadinovic A, Hann-von-Weyhern C, Protic M, Nissan A, Faries MB, Daumer M, Bilchik AJ, Itzhak A, Brücher BL.

J Am Coll Surg. 2013 Aug;217(2):324-35. doi: 10.1016/j.jamcollsurg.2013.02.031. Epub 2013 May 19. Review. No abstract available.

PMID:
23697834

Supplemental Content

Loading ...
Support Center